G1 THERAPEUTICS INC's ticker is GTHX and the CUSIP is 3621LQ109. A total of 94 filers reported holding G1 THERAPEUTICS INC in Q1 2018. The put-call ratio across all filers is - and the average weighting 0.2%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2021 | $222,000 | -99.2% | 16,556 | -98.6% | 0.00% | -100.0% |
| Q3 2019 | $27,016,000 | -28.6% | 1,185,958 | -3.9% | 0.02% | -25.0% |
| Q2 2019 | $37,846,000 | +84.7% | 1,234,358 | -0.0% | 0.02% | +81.8% |
| Q1 2019 | $20,495,000 | -13.3% | 1,234,658 | -0.0% | 0.01% | -21.4% |
| Q4 2018 | $23,648,000 | -61.1% | 1,234,858 | +6.1% | 0.01% | -53.3% |
| Q3 2018 | $60,864,000 | +9.5% | 1,163,958 | -9.0% | 0.03% | +3.4% |
| Q2 2018 | $55,584,000 | +14.7% | 1,278,968 | -2.2% | 0.03% | +16.0% |
| Q1 2018 | $48,458,000 | +59.1% | 1,307,916 | -14.8% | 0.02% | +66.7% |
| Q4 2017 | $30,467,000 | -10.1% | 1,535,616 | +10.1% | 0.02% | -11.8% |
| Q3 2017 | $33,906,000 | +218.3% | 1,394,616 | +128.4% | 0.02% | +240.0% |
| Q2 2017 | $10,651,000 | – | 610,700 | – | 0.01% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| MPM BioImpact LLC | 650,000 | $3,529,500 | 0.92% |
| CHI Advisors LLC | 333,945 | $1,813,321 | 0.48% |
| PVG ASSET MANAGEMENT CORP | 15,585 | $84,626 | 0.37% |
| Rhenman & Partners Asset Management AB | 370,000 | $2,009,100 | 0.21% |
| NEEDHAM INVESTMENT MANAGEMENT LLC | 184,000 | $999,120 | 0.18% |
| Birchview Capital, LP | 40,000 | $217 | 0.15% |
| XTX Topco Ltd | 102,282 | $555,391 | 0.12% |
| Tekla Capital Management LLC | 423,869 | $2,301,609 | 0.09% |
| Woodline Partners LP | 1,028,967 | $5,587,291 | 0.08% |
| Curi Wealth Management, LLC | 81,009 | $439,879 | 0.06% |